Equities researchers at StockNews.com began coverage on shares of China Pharma (NYSE:CPHI – Get Free Report) in a note issued to investors on Monday. The firm set a “hold” rating on the stock.
China Pharma Trading Up 3.0 %
China Pharma stock opened at $0.26 on Monday. The stock has a 50-day moving average price of $0.29 and a 200 day moving average price of $0.38. China Pharma has a 52 week low of $0.24 and a 52 week high of $2.05. The company has a current ratio of 0.89, a quick ratio of 0.25 and a debt-to-equity ratio of 0.17.
China Pharma (NYSE:CPHI – Get Free Report) last posted its quarterly earnings data on Wednesday, May 15th. The company reported ($0.07) EPS for the quarter. The company had revenue of $1.37 million for the quarter. China Pharma had a negative return on equity of 54.31% and a negative net margin of 55.42%.
China Pharma Company Profile
China Pharma Holdings, Inc develops, manufactures, and markets generic and branded pharmaceutical, and biochemical products to hospitals and private retailers in the People's Republic of China. The company provides products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions.
See Also
- Five stocks we like better than China Pharma
- What Are the FAANG Stocks and Are They Good Investments?
- RXO Shares Surge Following New Acquisition Deal
- How to Use High Beta Stocks to Maximize Your Investing Profits
- 3 Stock Dips Insiders Are Buying: Vestis, Shenandoah, Treace
- NYSE Stocks Give Investors a Variety of Quality Options
- Biotech Stock Breakout: IBB Eyes Resistance with Amgen and Vertex
Receive News & Ratings for China Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for China Pharma and related companies with MarketBeat.com's FREE daily email newsletter.
